Grants and Contributions:
Title:
Development of Molecular Modeling Platform for Drug Design
Agreement Number:
980884
Agreement Value:
$50,000.00
Agreement Date:
Oct 15, 2021 - Mar 18, 2022
Description:
The project will implement and scale key components for a molecular modeling platform that can be used to design or modify drugs, and is capable of providing high-resolution insight into the interactions between molecules, beyond the existing abilities of commercial competitors.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V5N 1R1
Reference Number:
172-2021-2022-Q3-980884
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
709332134
Recipient Type:
For-profit organization
Recipient's Legal Name:
HTUO Biosciences Inc.
Federal Riding Name:
Vancouver East
Federal Riding Number:
59035
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410